Gene: SBK1
Official Full Name: SH3 domain binding kinase 1provided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in chromatin remodeling. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14341 | SBK1 Knockout cell line (HCT 116) | Human | SBK1 | 1:2~1:4 | Negative | Online Inquiry |
KO14342 | SBK1 Knockout cell line (HEK293) | Human | SBK1 | 1:3~1:6 | Negative | Online Inquiry |
SBK1 Gene Knockout Cell Lines are specifically engineered cellular systems designed to enable the study of SBK1 gene function by effectively disrupting its expression. This innovative biological tool employs CRISPR/Cas9 technology, a groundbreaking genome editing technique that allows for precise modification of the cellular genome. By targeting and creating double-strand breaks in the SBK1 gene, these knockout cell lines facilitate the investigation of the gene's role in various cellular processes, particularly those related to signal transduction, cell growth, and differentiation.
The primary function of the SBK1 Gene Knockout Cell Lines lies in their ability to provide an experimental model that reflects the depletion of SBK1 activity, allowing researchers to delve deeper into its molecular mechanisms. These cells serve critical roles in elucidating the pathways influenced by SBK1, enabling investigations into its involvement in diseases such as cancer, neurodegeneration, and metabolic disorders. The knowledge gained can inform therapeutic strategies and potentially lead to the development of targeted interventions.
What sets the SBK1 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability. Traditional methods of gene silencing, such as RNA interference, can be less effective due to off-target effects, while the CRISPR/Cas9 method ensures accurate and consistent disruption of the intended gene. This precision fosters reproducibility in research findings and enhances confidence in data interpretations.
For researchers and clinicians, the SBK1 Gene Knockout Cell Lines represent a valuable resource, allowing for the streamlined investigation of gene function. Their ability to accelerate molecular studies significantly can expedite the development of novel therapeutics, making them indispensable tools in cutting-edge biomedical research.
Our company prides itself on advancing scientific inquiry through the provision of high-quality biological products. We are committed to supporting researchers and clinicians in their quests to unravel the complexities of gene function, thereby driving innovation in various fields of healthcare and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.